Skip Navigation
You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
U.S. Department of Health and Human Services
•
National Institutes of Health
Advanced Search
NIAID Home
Health & Research A to Z
Labs & Scientific Resources
Funding
About NIAID
News & Events
NIAID
>
Labs & Scientific Resources
>
Resources for Researchers
>
Microbiology and Infectious Diseases Resources
>
VTEU Resources for Researchers
Resources for Researchers
Microbiology and Infectious Diseases Resources
VTEU Resources for Researchers
Eligibility Criteria
Assurances to Users
Application Process
Prioritization and Approval
User Requirements
Skip Website Tools
Website Tools
Email this page
Print this page
Get email updates
Order publications
Skip Stay Connected
Stay Connected
Contact Info
Mary Smith
Project Manager
mary.smith@nih.gov
Additional Information From NIAID
All microbiology and infectious diseases resources (non HIV/AIDS)
All NIAID resources
Background information about the VTEU program
Javascript Error
Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.
Microbiology and Infectious Diseases Resources
Skip Content Marketing
Share this:
User Requirements
Concept proposals require written approval by the Project Officer and study budgets require approval by the Contracting Officer prior to initiating protocol development.
The Division of Microbiology and Infectious Diseases (DMID) will sponsor the investigational new drug (IND) application for the study.
Study product will be stored in DMID’s central repository.
The protocol must be approved by DMID prior to study initiation.
Protocols must be implemented within 12 months of concept approval in order to secure funding. Studies not initiated within this timeframe must undergo re-approval by the VTEU Oversight Committee before proceeding with further protocol development.
Last Updated November 29, 2012